The mammaglobin gene encodes a novel secreted protein whose corresponding mRNA is frequently up-regulated in human breast cancer. In non-malignant tissues, expression is also strictly limited to the mammary epithelium. To better understand the mechanisms controlling these patterns of expression, we have isolated the human mammaglobin gene and performed an initial assessment of its promoter activity. Mammaglobin gene architecture is very similar to that of a family of related genes that includes uteroglobin and rat prostatein subunits C1, C2, and C3. However, the mammaglobin gene itself is not well conserved phylogenetically. The human mammaglobin gene is localized by¯uorescent in situ hybridization to chromosome 11 band q13, a genomic region frequently ampli®ed in breast neoplasia. The sequence of proximal 1 kb of mammaglobin promoter contains several potential transcriptional control elements and directs high-level expression of a transfected reporter construct in human breast tumor cell lines. However, comparable levels of reporter gene expression are also seen in non-mammary human cell lines. These data suggest that, unlike related gene family members, the striking breast-speci®c expression and tumor-associated overexpression of mammaglobin is mediated by complex transcriptional control at more distal sequence elements.
Introduction
The evolution of human breast cancer is accompanied by multiple changes in gene expression. Identi®cation of these genes and elucidation of the mechanisms controlling their patterns of expression could lead to novel diagnostic and therapeutic targets for the clinical management of breast cancer. Toward this goal, we have isolated several cDNAs that are dierentially expressed between primary human breast tumors and patient-matched normal breast tissue (Watson and Fleming, 1994) . We have further characterized and named one of these novel cDNAs mammaglobin (Watson and Fleming, 1996) .
Previous sequence analysis has demonstrated that the 93 amino acid polypeptide encoded by the mammaglobin cDNA is homologous to a family of proteins that includes rat prostatic steroid binding protein (prostatein) subunit C3 (rPSC3) , rabbit uteroglobin (rUg) (Miele et al., 1987) , and the Clara Cell 10 kD protein (CC10) from multiple species (Miele et al., 1994) . Prostatein is the major secretory protein in the rat ventral prostate and is a tetramer composed of three dierent 8 ± 12 kD polypeptides, rPSC1, rPSC2 and rPSC3 (Lea et al., 1979) . The corresponding rPSC1, rPSC2 and rPSC3 genes are thought to have arisen from a common ancestral gene (Parker et al., 1982) . The rPSC3 gene itself is duplicated in the rat genome; rPSC3(I) is actively transcribed in the prostate while rPSC3(II) is transcriptionally silent, presumably due to a promoter mutation . The transcriptional regulation of the rPSC3(I) gene by androgens has been studied extensively and the 5'-regulatory region of this gene linked to the SV40 T antigen promotes both prostate and mammary tumorigenesis in a transgenic mouse model (Allison et al, 1989; Maroulakou et al., 1994) .
Transcription of the rabbit uteroglobin gene was initially characterized in uterine endometrial tissue, but has since been found at much lower levels in other epithelial tissues including lung, breast, and prostate (Miele et al., 1987) . Like the rPSC3 gene, uteroglobin gene transcription is regulated by tissuespeci®c responses to steroid hormones and transcriptional control of this gene has been studied extensively both in vitro and in transgenic animal models (Sandmoller et al, 1994) . The human, mouse, rat and monkey CC10 genes are thought to be the interspecies homologs of rabbit uteroglobin (Miele et al., 1994) . The promoters of the mouse and rat CC10 genes have been best studied and a number of speci®c DNA sequences and corresponding binding proteins that direct the predominantly lung-speci®c expression of these genes have been identi®ed (Dennig et al, 1995; Toonen et al., 1996; Ray et al., 1996) .
Although the functional signi®cance of mammaglobin in the process of mammary tumorigenesis is currently unclear, mammaglobin displays two characteristics to suggest that its expression is at least partially relevant to breast cancer biology (Watson and Fleming, 1996) . First, both Northern blot analysis and a more sensitive and extensive RT ± PCR analysis of 15 dierent adult human tissues have demonstrated that mammaglobin expression is restricted to the mammary gland. Second, mammaglobin is frequently over-expressed in human breast tumor cell lines and primary breast tumors relative to nonmalignant breast tissue. In a preliminary survey, ®ve of 10 (50%) breast carcinoma cell lines, eight of 35 (23%) primary human breast tumors, and 13 of 21 (62%) metastatic breast tumors exhibited high levels of mammaglobin mRNA. Mammaglobin expression among tumors does not appear to correlate with histology, tumor grade, tumor stage, or hormone receptor status. Therefore, over-expression of mammaglobin may be restricted to a lineagespeci®c or transformation-speci®c subset of primary human breast tumors. Based on its homology to a family of hormonally regulated genes, its breastspeci®c expression, and its frequent over-expression in human breast cancer, we have initiated studies to isolate the mammaglobin gene and determine the mechanisms that regulate its expression.
Results and Discussion
Isolation and sequencing of the mammaglobin gene Two independent, overlapping genomic clones were isolated from a library screen using a full-length mammaglobin cDNA probe. One of these clones (lMAM2) was used to subclone a 4.3 kb SalI fragment. This fragment encompasses *1000 bp of 5' nontranscribed sequence, *3100 bp of the mammaglobin gene, and *200 bp of 3' nontranscribed sequence. Sequencing of this genomic fragment demonstrated 100% concordance with the mammaglobin cDNA derived from the human breast tumor cell line, MDA ± MB415 as well as a cDNA derived from normal human breast tissue. Sequence divergence between the cDNA and genomic clones also allowed precise determination of exon/intron boundaries. As shown in Figure 1a , the mammaglobin gene is composed of 3 exons (119 bp, 188 bp and 199 bp) and 2 introns (603 bp and 1888 bp). This exon/intron Figure 1 (a) Restriction map and organization of the human mammaglobin gene. The extent of the SalI subclone, pMAM4.3, is shown. Nontranslated exon sequence is denoted by open boxes; translated sequence is denoted by ®lled boxes. Shaded regions within upstream nontranscribed and intron b segments represent a human Alu repeat and an anonymous, highly repetitive element, respectively. The location of a dinucleotide CA repeat is also indicated. S, SalI; B, BamHI; Sc, SacI; X, XbaI, H, HindIII; P, PstI; N, NcoI. Inset: Dot plot self-comparison of the mammaglobin gene. Nucleotide number is shown on the ordinate and the schematic of the gene is scaled on the abscissa. In addition to the diagonal line of identity, a cluster of directly repetitive sequence is apparent in the 5' end of intron b. (b) Comparison of exon/intron splice sites between the human mammaglobin (hMAM), rat prostatic steroid binding protein subunit C3 (rPSC3), and human CC10 (hCC10) genes. Splice donor and acceptor consensus sequences are underlined. Amino acids are numbered in reference to the translational start codon of each gene. Highly conserved amino acids are denoted by vertical lines arrangement and corresponding splice sites are well conserved between mammaglobin, rPSC3, and CC10 (Figure 1b) , suggesting that these genes constitute a multigene family derived from a common ancestral sequence. Sequencing of the mammaglobin gene also revealed a number of repetitive sequences (Figure 1a) , including a human-speci®c alu repeat motif in the 5' nontranscribed region. Dot plot analysis to identify direct and inverted repeats (Figure 1a , inset) detected a highly repetitive 500 nucleotide sequence within intron b. Finally, a dinucleotide CA repeat was found within the 3' nontranscribed region of the gene.
Phylogenetic conservation of the mammaglobin gene
The CC10 gene has been isolated from human, monkey, mouse and rat. Homologies between these species range from 50 ± 90% (Miele et al., 1994) . On the other hand, the rat prostatein genes have not been identi®ed in other species. To determine the extent of interspecies conservation of the mammaglobin gene and evaluate its potential utility in studying animal models of mammary tumorigenesis, we examined genomic DNA from multiple organisms using low stringency Southern blot hybridization with the pMAM4.3 genomic subclone as a probe. As shown in Figure 2 , this probe detected the two expected XbaI genomic fragments in both human and chimpanzee DNA. However, even under low stringency conditions, no cross-hybridizing genomic fragments were detected in Rhesus monkey nor in other non-primate mammals. This result indicates that either mammaglobin is poorly conserved or absent in the genomes of these species. The observations that mammaglobin is poorly conserved or even absent in other mammalian genomes and that its expression is very breast speci®c together suggest that overexpression of this gene may be associated with a very speci®c aspect of human mammary tumorigenesis.
Chromosomal localization
To determine the human chromosomal location of the mammaglobin gene, both lambda genomic clones and the pMAM4.3 plasmid subclone were used for high stringency FISH analysis. From a total of 300 randomly selected metaphases, 243 had both copies of chromosome 11 labeled. Symmetrical¯uorescent signal was also observed on chromosome 15. Using a procedure for direct visualization of the¯uorescent signal on banded chromosomes, the location of the hybridization signal could be assigned to the regions 11q12.3-13.1 and 15q23-24 ( Figure 3a) .
To con®rm the results of FISH analysis, two mammaglobin-speci®c oligonucleotides were implemented in a PCR-based screen of the Genebridge 4 radiation hybrid cell line panel (Hudson et al., 1995) . Results from this analysis localized mammaglobin to within 4.60 cR of the marker AFM350WA9 and 2.02 cR of the marker CHCL.GATA46A12, thus con®rming the 11q12.3-13.1 placement of FISH analysis ( Figure 3b) . However, the screen failed to identify a second location for mammaglobin at 15q23-24, indicating that a homologous but not identical gene sequence may be present at this locus. In support of this idea, at least one other cross hybridizing genomic fragment is present in low stringency Southern blot analysis of human and chimpanzee genomes (Figure 2 ). Much like the rat prostatein genes, there may be multiple copies of mammaglobin-like genes in the human genome. It is also interesting to note that both the mammaglobin and human CC10 genes map to neighboring chromosomal locations, suggesting that 11q12.3-13.1 may harbor a cluster of`globin' gene sequences.
Genomic analysis of human breast tumors
Intriguingly, chromosome 11q13 is frequently ampli®ed in breast carcinoma and harbors a number of known oncogenes such as int-2 and cyclinD (Fantl et al., 1993) . The cyclinD gene is frequently ampli®ed in human breast cancer, and overexpression of this gene has been associated with breast cancer progression (Gillett et al., 1994) . The primary localization of the mammaglobin gene to 11q12.3-13.1 thus suggested that high levels of mammaglobin expression previously observed in human breast tumors might also be explained by gene ampli®cation. To address this issue, the human mammaglobin genomic clone pMAM4.3 was used as a probe in Southern blot analysis of genomic DNAs from several cell lines and tumors that had previously demonstrated greater than tenfold increases in mammaglobin mRNA levels relative to non-malignant breast tissue. As shown in Figure 4 , no gene ampli®cation or gross rearrangements were detected in these tumors or cell lines. Similar results were obtained with multiple other restriction analysis of tumor DNA, indicating that mammaglobin over-expression in breast cancer does not appear to be due to gene ampli®cation or gross gene rearrangement. Ten micrograms of genomic DNA from each indicated mammalian species was digested with XbaI, electrophoresed, and subjected to Southern Blot analysis using the pMAM4.3 genomic DNA probe under low stringency conditions. The predicted doublet of approximately 4.0 kb and 3.5 kb fragments is seen in human DNA and, to a lesser extent, chimpanzee DNA. Less intense, cross hybridizing bands are also seen in human, chimpanzee, and rhesus monkey DNA. Note that the band present in bovine DNA represents cross-hybridization to satellite DNA sequence under reduced stringency conditions
The mammaglobin gene promoter
Since the high levels of mammaglobin expression seen in breast tumors and tumor cell lines could not be attributed to genomic alterations, we next examined the role of the mammaglobin promoter and transcriptional regulatory region in directing both breast-speci®c and tumor associated expression. Figure 5 shows the sequence of the proximal 1000 bp of mammaglobin gene promoter sequence. Both S1 and primer extension analysis localized a relatively uniform transcriptional start site, 27 bp downstream of a sequence that contains a weak TATA consensus element (AA-TAAATAGAG). This sequence is present at the same location in the actively transcribed rPSC3(I) gene . The transcriptional start site of the mammaglobin gene was identical in tumor cell lines that express high levels of the transcript (MDA ± MB415) as well as cell lines that express much lower levels of the mammaglobin mRNA (BT474, MDA ± MB175), thus indicating that the relative levels of message seen in these dierent breast tumor cell lines is not due to the activity of dierent transcriptional initiation sites. Sequence analysis of the promoter region revealed several previously characterized nucleotide motifs. The most signi®cant of these are denoted in Figure 5 . One hallmark of uteroglobin gene family members is their transcriptional regulation by steroid hormones and the presence of classic steroid hormone-responsive elements within 1000 bp proximity of their transcriptional start site (Miele et al., 1994) . Based on its relatedness to this gene family and its expression in the hormonally responsive breast epithelium, we predicted that mammaglobin expression would also be regulated by steroid hormones, hormone receptors, and their corresponding response elements. Studies in our laboratory, however, have revealed that mammaglobin transcription is not modulated by estradiol, progesterone, dexamethasone, or androgens in receptor positive breast tumor cell lines such as MCF7 and T47D (MAW, unpublished data). In support of this observation, we were also unable to locate any classical steroid responsive elements within the mammaglobin promoter. However, an imperfect dyad symmetry element reminiscent of a classical estrogen response element is located within the human-speci®c alu repeat sequence 843 bp upstream of the transcriptional start site. This sequence (GGTCAN 17 TGACCT) In the center is a previously reported radiation hybrid map (James et al., 1994) with a number relevant gene markers indicated. Numbers denote approximate distances between markers expressed in centirays. To the right is mapping data obtained using mammaglobin primer sequences against the Genebridge 4 radiation hybrid panel. Placement of the mammaglobin gene and other markers are indicated. Numbers denote cumulative distance between mammaglobin and a given marker expressed in centirays has evolved by point mutation from an ancestral alu element and confers estrogen responsiveness to reporter genes. In fact, the BRCA1 gene contains an identical sequence within its 5' nontranscribed region (Norris et al., 1995) . A second imperfect dyad symmetry element (GGTCAN 38 TGACCT) is also located in the 3' nontranscribed region of the mammaglobin gene (nt. 3100) while a sequence at nt. 2243 (AGTtCGgagTGTTCT) is similar to a functional androgen response element in the rPSC3(I) gene (Celis et al., 1993) . Two pairs of purine-rich repeats (`A' and`B' in Figure 5 ) at nucleotides 7668, 7199 and 7216, 7166 contains a polyoma enhancer-related (PEA3) motif, AGGAAG. The PEA3 transcription factor activates transcription of the vimentin gene in mammary epithelial cells and high levels of expression are associated with the metastic phenotype . Overexpression of the oncogene her2/neu in human breast tumors is also associated with upregulated PEA3 expression (Scott et al., 1994) . Interestingly, both mammaglobin and her2/neu share identical PEA3 binding motifs (GAGGAA) within approximately similar locations relative to their respective TATA boxes. These observations suggest that PEA3 or other ets-related transcription factors may mediate the breast tumor-associated expression of mammaglobin.
A number of binding sites for the Sp family of transcription factors (CACCC) are also present at 7806, 7570, 7563, and +28. These sequences have been shown to control transcription from the rabbit uteroglobin promoter (Dennig et al., 1995) . Finally, an Ap-1 consensus site (TGACTC) was identi®ed at nucleotide 775.
A comparison of the mammaglobin promoter with the human CC10 gene promoter and the rat rPSC3 promoter failed to identify additional homologies to sequences previously shown to direct epithelial expression and hormonal control of these genes. Binding sites for the octomer, forkhead/HNF, and NKx homeobox transcription factor families present in the promoter of the human CC10 gene are not present in the mammaglobin gene (Toonen et al., 1996; Ray et al., 1996) .
Finally, because of its striking breast-speci®c expression, we scanned the mammaglobin gene sequence for elements homologous to those found in the promoters of the breast speci®c genes whey acidic protein (Mcknight et al., 1992) and b-casein (Greenberg et al., 1992). Binding sites for factors such as MGF/Stat5 (Wakao et al., 1994 ) that direct the mammary-speci®c expression of b casein were not identi®ed. However, a palindromic sequence at nt. 7589 (TGATN 10 ATCA) is similar to the binding site Figure 5 Nucleotide sequence of the proximal 1000 bp of the mammaglobin gene upstream region. The 5' end of the previously reported cDNA sequence is indicated by an open arrow. The preferred transcriptional start sites, as demonstrated by S1 and primer extension analysis, are indicated by solid diamonds. The putative TATA sequence is boxed and the upstream Alu repeat is underlined. The ERE-like palindrome within the Alu repeat is denoted by arrows. Sp-family binding motifs are indicated by single overlines, PEA3 binding sites are indicated by double overlines, and an AP1 element is denoted by a thick overline. Purine-rich direct repeats that contain additional PEA3 binding sites are shaded and indicated`A' and`B'. Numbering is based on the transcriptional start site of +1, as determined by primer extension and S1 analysis described in this report of pregnancy-speci®c mammary factor (PMF). This DNA binding protein mediates the progesterone repression of the b casein gene (Lee and Oka, 1992) . Interestingly, synthesis of both b casein and WAP is associated with lactogenesis and gene transcription is upregulated by prolactin and other lactogenic hormones. Preliminary data from our laboratory suggests that unlike these genes, normal mammaglobin expression is not associated with lactation, but instead with mammary gland proliferation and terminal dierentiation, such as occurs during pregnancy (MAW, unpublished data). Based on this observation, it may be expected that a novel set of regulatory elements not present in b casein, WAP, or other milk protein genes may control mammaglobin's pattern of growth-related and breast-speci®c expression. Since there are few other well characterized examples of breast-speci®c gene expression, future identi®cation of these elements may provide new tools for understanding aberrant gene expression in the progression of human mammary tumorigenesis.
Transcriptional activity conferred by the cloned mammaglobin promoter sequence
To test the activity of the proximal 1000 bp of the mammaglobin promoter, several nested promoter deletions were created and assayed to determine whether they could direct expression of a luciferase reporter gene. These assays were performed in both breast and non-breast tumor cell lines that differentially express the endogenous mammaglobin gene (Figure 6 ). The 1000 bp mammaglobin promoter conferred a tenfold increase in luciferase expression as compared to the promoterless construct in the MDA-MB415 breast tumor cell line. However, a similar level of activity was seen in non-mammary cell lines (HeLa, E2). Moreover, in breast tumor cell line that does not express endogenous mammaglobin (MCF7), the 1000 bp promoter conferred a 20-fold increase in expression. Removal of the distal most 400 bp of the promoter that includes the alu repeat and putative estrogen responsive element attenuated expression in the estrogen receptor positive cell line MCF7. This same deletion had no eect in the estrogen receptor negative cell line MDA-MB415. Further deletions down to nucleotide 7350 had a small but variable decremental eect on reporter expression in each tested cell line. Finally, removal of purine-repeats`A' and`B' and the putative AP1 binding site, leaving only 75 bp of promoter sequence, rendered the promoter essentially inactive in all cell lines. These data suggest that determinants of the basal level of mammaglobin expression reside within the proximal 350 bp of the promoter. Despite a number of other potential regulatory elements identi®ed in the proximal 1000 bp of mammaglobin promoter sequence, mechanisms conferring both breast-and/or tumor-speci®c expression patterns must employ more distally located transcriptional control elements or rely on alternatives to transcriptional control.
It is possible, for example, that the endogenous mammaglobin gene is mutated and/or deleted in nonexpressing breast tumors and cell lines such as MCF7. Although current studies have focused on mechanisms of mammaglobin gene overexpression, many primary human breast tumors lack detectable mammaglobin mRNA. Paradoxically, the 11q12.3-13.1 locus is also frequently deleted in human breast cancer (Zhuang et al., 1995) . While there are numerous expressed genes in this region that could be deleted, mammaglobin is certainly one candidate. The presence of multiple repetitive and presumably polymorphic sequences within the mammaglobin gene should prove useful for further de®ning this deleted region.
It is also possible that in the absence of the proper genomic context, the transfected mammaglobin promoter construct can not properly regulate cellspeci®c expression. This may be due to dierential methylation or other similar mechanisms of transcriptional insulation of the endogenous mammaglobin binding motif) , and an ellipse (ERE-like element). Alu sequence is indicated by the shaded region. To the right is the transcriptional activity of each construct, transfected into the indicated cell line. Activity is expressed as fold-induction over a promoterless reporter, after normalization to a co-transfected b-galactosidase expression plasmid gene among dierent cell lines and tumors. For example, the human epithelial-speci®c cytokeratin 18 gene contains two upstream alu repeats within a 1000 bp proximity to the transcriptional start site. This gene is expressed promiscuously in ®broblast and myoblast cells when transfected in vitro, but demonstrates appropriate tissue-speci®c expression in transgenic mice (Nezanov and Oshima, 1993) . A role for transcriptional insulation by RNA Polymerase III transcription of the upstream alu element has been proposed to explain this eect (Thorey et al., 1993) . A similar mechanism has been proposed for several other genes (Britten, 1996) and may also be responsible for the discrepancy seen between endogenous and transfected mammaglobin promoter activities. Therefore, future studies employing a larger region of the mammaglobin gene promoter in a transgenic mouse model should prove bene®cial to understanding the complex regulation of this breast speci®c gene in both normal and malignant mammary epithelial cells.
Materials and methods

Isolation of a mammaglobin genomic clone
A lFIXII human placental genomic library (Stratagene) was screened with a previously isolated mammaglobin cDNA (Watson and Fleming, 1996) radiolabeled with 32 P and the Rediprime labeling kit (Amersham). Filters were hybridized at 558C for 16 h using Rapid-Hyb hybridization buer (Amersham), washed twice at room temperature for 15 min in 26SSC/0.1% SDS, and washed twice again at 558C for 1 h in 0.26SSC/0.1% SDS. Candidate positive plaques were chosen and subjected to three additional rounds of plaque puri®cation. Once a pure population of hybridization-positive plaques was obtained, large scale l DNA puri®cation was performed using standard plate lysis and the Qiagen lambda kit (Qiagen). Puri®ed genomic DNA was subjected to multiple dierent restriction digests, gel electrophoresis, and Southern blot analysis using a radiolabeled mammaglobin cDNA probe. Appropriately sized, hybridization-positive restriction fragments were subcloned into pGME3 (Promega) and subjected to sequence analysis using 32 P-labeled, mammaglobin sequence-speci®c oligonucleotides and the fmol sequencing kit (Promega).
Chromosomal mapping
Chromosomes obtained from peripheral lymphocyte cultures after methotrexate/thymidine release treatments were used for¯uorescence in situ hybridization (FISH). Lambda clone lMAM1 and subclone pMAM4.3 were labeled with biotin or digoxigenin using a random-prime DNA labeling kit (Boehringer-Mannheim). FISH was performed as perviously described (Zimonjic et al., 1994) . Slides were pretreated with RNase, denatured in 26SSC/ 70% formamide for 2 min at 708C, and hybridized with 200 ng of DNA probe in 26SSC/50% formamide/10% dextran sulfate/26Denhart's/1% Tween20 for 18 h at 378C. Post-hybridization wash was in 0.16SSC at 608C and 26SSC at 378C for high and low stringency conditions, respectively. Labeled DNA was detected bȳ uorescein isothiocyanate conjugated avidin DCS (Vector Laboratories) or rhodamine conjugated antidigoxigenin (Boehringer Mannheim), as appropriate. Chromosomes were counterstained with propidium iodide or 4, 6-diamino-2-phenyl-indole. Digital images of selected metaphase spreads were recorded during sequential excitation of each¯uorochrome. Image analysis and chromosome identi®cation were performed as previously described (Zimonjic et al., 1995) .
Mammaglobin speci®c primers MG206 (nt.7337, 5'-GAGATGTCAGTGGATGAGAA-3') and MG103 (nt. 6, 5'-CAAGGATCAAGGAAGCCGCTG-3') were used for PCR-based radiation hybrid screening of the Genebridge 4 cell line panel (Hudson et al., 1995) . Reactions and data analysis were performed by Research Genetics and using the Whitehead/MIT server (http://www-genome.wi.mit.edu).
Southern blot analysis
Twenty micrograms of genomic DNA was digested with the indicated restriction enzymes and subjected to 0.8% agarose gel electrophoresis using standard methodology. Gels were blotted to Nytran Plus membrane (Scleicher & Schuell) using 106SSC transfer buer and following the supplier's protocol. Baked membranes were hybridized with 5610 5 c.p.m./ml of 32 P radiolabeled genomic subclone pMAM4.3 in Rapid-Hyb buer (Amersham). Hybridization was conducted for 16 h at 658C for high stringency and 508C for low stringency hybridization experiments. Blots were washed twice for 15 min at room temperature in 26SSC/0.1% SDS. For high stringency experiments, ®lters were then washed twice for 1 h at 658C in 0.26SSC/0.1% SDS. For low stringency experiments, ®lters were washed twice for 1 h at 508C in 26SSC/0.1% SDS. Washed ®lters were exposed to ®lm for 16 ± 72 h.
S1 and primer extension analysis
Total RNA was isolated from 10 6 cells using Trizol reagent (Life Technologies). For S1 nuclease analysis, oligonucleotides MG206 and MGT7 (nt. 97, 5'-GGATCC-TAATACGACTCACTATAGGGAGTGCGTAGCAGTG-CTGGGAGAG-3') were used to generate a 455 bp PCR fragment from the pMAM4.3 plasmid template under standard PCR conditions. This PCR fragment was then used in a subsequent asymmetric PCR reaction with 400 ng of the oligonucleotide MGPE (nt. 90, 5' -CAGCATGAGGACCATCAGCAACTTCATGGT -3'), 25 mM each dATP, TTP, dGTP, 2.5 mM dCTP and 50 mCi (10 mCi/ml) [ 32 P]-adCTP under standard PCR conditions for 20 cycles of ampli®cation. The resulting radiolabeled, single stranded DNA probe was puri®ed over a G25 sephadex column (Pharmacia). Hybridization and nuclease treatment were performed using the S1-Assay kit (Ambion) following the supplier's`direct-load' protocol. For each sample 5610 5 c.p.m. of single stranded, radiolabeled PCR product was hybridized to 10 mg of indicated total RNA at 428C for 16 h. Digested samples were electrophoresed on a 6% polyacrylamide sequencing gel along with a sequencing run employing the MGPE primer on the pMAM4.3 plasmid template. This sequence was used to precisely identify the 5' most nucleotide protected by the S1 probe. For primer extension analysis, the oligonucleotide MGPE was end labeled with [ 32 P-g]ATP using T4 polynucleotide kinase and standard methodology. Hybridization and primer extension was performed using 10 mg of indicated RNAs and the Superscript Pre-Ampli®cation System (Life Technologies) following the supplier's protocol for gene-speci®c priming. Primer extension products were subjected to electrophoresis as described above with the MGPE sequencing ladder to precisely identify the 5' most nucleotide of extended product.
Mammaglobin promoter constructs
Sequence of the mammaglobin promoter was used to design a set of 5' oligonucleotides: MG202 (nt. 7869, 5'-TAGTAGAGAAGGGGTTTCTC-3'), MG204 (nt. 7598, 5'-CCTCATCCCTGATTCCAAAT-3'), and MG206, and one common 3' oligonucleotide, MG103Kpn (nt. 6, 5'-CGGGGTACCAAGGATCAAGGAAGCCGCT-3'). Primer pairs were used with the pMAM4.3 plasmid template in a standard PCR reaction for 30 cycles with Vent DNA polymerase (New England Biolabs). The resulting PCR products representing nested promoter deletions were gel puri®ed, digested with KpnI, and ligated into the SmaI and KpnI sites of the pGL2 basic luciferase reporter vector (Promega). The 208 construct was created by digesting the MG206/MG103Kpn PCR fragment with HincII and KpnI, and ligating this 93 bp subfragment into the pGL2 vector. Each reporter construct was sequenced to ensure no mutations were introduced during ampli®cation.
Luciferase reporter assay
Indicated cell lines (MDA-MB415, MCF7, HeLa, E2) were grown in six well plates to 70% con¯uency in DMEM supplemented with 10% FCS. One microgram of indicated mammaglobin-luciferase reporter plasmid construct was cotransfected with one microgram of CMV-b galactosidase control reporter plasmid (Promega) using a standard calcium phosphate precipitation technique. After 16 h, the media was replaced for an additional 48 h. Cells were washed with PBS and harvested in 200 ml of lysis buer provided by the manufacturer (Tropix). Cells extracts were used directly with a luciferase assay system (Tropix) in a Moonglow 20000 luminometer (Analytical Luminescence Laboratory) employing manual injection mode. After incubation at 488C for 30 min to inactivate endogenous cellular enzyme activity, extracts were also used to assay for b galactosidase activity using the Galacto-light Plus assay system (Tropix) in the same instrument. For each experiment, transfections were performed in duplicate. Duplicate reactions that varied by greater than 10% were discounted from analysis. Relative mammaglobin promoter activity was then calculated by dividing average luciferase activity by average b galactosidase activity for each transfection. Transfection experiments were repeated a minimum of two times to ensure reproducibility.
